Steeper has grown exponentially providing vital patient care and expertly manufacturing devices in the fields of orthotics and assistive technology having been awarded NHS contracts in these fields since the 1980s.
In 2015 the company rebranded to the original family name given to the firm almost a century before; and after being owned by several private equity firms to enable growth, in 2017 John Midgley and Paul Steeper, grandson of Mr. Hugh Steeper, became the owners of Steeper Group.
In 2020, the company acquired the prestigious Espire™ Elbow product range; giving five choices of prosthetic elbow including the award winning, powered Espire Pro with natural free swing and the Espire Classic Plus which can be used in combination with a wide range of terminal devices. The whole range is deigned to be anatomically correct and offers patient choice with a variety of colours and design finishes.
The turning point
The company now prides itself in being not only an expert manufacturer, providing enablement devices worldwide and making a difference to thousands of patients every day but is also an expert service provider, drawing on the expertise previously gained by Mr. Hugh Steeper and innovating utilising the latest techniques and technologies to enable our clinicians to offer the best possible outcome, and our patient’s excellence in the provision of care.
Paul Steeper, CEO said
“It’s incredibly rewarding that the Steeper name continues to be a success across enablement devices, our teams know that everything we do impacts upon a patient’s life and everyone at Steeper strives to create positive turning points in people’s lives.
Our 100th year will see global product launches, new supplier partnerships, improved ways of working and of course plenty of celebrations when its possible to do so, I’m excited about what the future holds for Steeper Group.”
100 Year Case Study